The Alagille Syndrome Gene Panel by NGS is a specialized molecular test designed to detect genetic mutations associated with Alagille Syndrome. Metropolis Healthcare performs this advanced test using next-generation sequencing to analyze key genes responsible for this multisystem disorder. It helps confirm diagnosis, guide clinical management, and support genetic counseling for affected families. This test is especially useful when clinical signs suggest a hereditary liver, heart, or developmental condition.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0164
Frequently Asked Questions (FAQ's):
What does this test include at Metropolis Healthcare?
It includes targeted next-generation sequencing of genes known to cause Alagille Syndrome.
How does Metropolis Healthcare perform this test?
DNA is extracted from an EDTA blood sample and analyzed using high-precision NGS technology to detect disease-related variants.
Who should take this test at Metropolis Healthcare?
Individuals with suspected Alagille Syndrome presenting with liver disease, heart defects, facial features, or a relevant family history.
What sample is required at Metropolis Healthcare?
A routine EDTA blood sample is needed for DNA extraction and sequencing.
How does this panel help clinicians at Metropolis Healthcare?
It confirms the genetic cause, supports prognosis, and enables appropriate management and family counseling.
Is any preparation needed before giving the sample at Metropolis Healthcare?
No special preparation or fasting is required for this blood-based test.
How long does the test take at Metropolis Healthcare?
Due to detailed sequencing, the analysis usually takes several days to weeks.
When will I receive the report from Metropolis Healthcare?
Reports are provided as per the molecular diagnostics timeline, with expert interpretation included.